Doximity's stock plummeted 5.02% during intraday trading on Thursday, as investors reacted to the company's upcoming quarterly earnings report.
The healthcare technology company is scheduled to report its third-quarter earnings after market close, with analysts expecting earnings per share of $0.45 according to FactSet estimates. The pre-earnings selloff suggests investor caution ahead of the financial results announcement.